文献速递焦虑、强迫与应激相关障碍会诊联络精神医学

基于神经科学视角的强迫症个案概念化与治疗规划:综述

Neuroscientifically Informed Formulation and Treatment Planning for Patients With Obsessive-Compulsive Disorder: A Review.
PubMed 文献 · JAMA Psychiatry · 2018-01-01

本教育性综述围绕现象学与症状维度、恐惧条件化与消退、神经化学、遗传与动物模型、神经环路与神经治疗等主题,整合神经科学视角探讨强迫症的个案概念化与治疗规划。文章强调异常恐惧消退是暴露与反应阻止疗法的核心机制,并讨论谷氨酸能与γ-氨基丁酸能系统失调、皮层-纹状体-丘脑-皮层环路功能障碍及靶向该环路的神经治疗进展,旨在促进神经科学发现向临床实践转化。

要点

  • 症状维度有助于理解强迫症表型异质性并推动个体化治疗。
  • 异常恐惧消退是强迫症核心机制及暴露与反应阻止疗法的基础。
  • 皮层-纹状体-丘脑-皮层环路失调是神经治疗干预的重要靶点。

核心结论

  • 上述神经科学主题共同为强迫症患者的个案概念化与治疗规划提供依据。
  • 最终目标是加强临床医生与研究者交流,促进神经科学进展转化为更好的强迫症照护。

研究设计与样本

  • 本文为教育性综述,围绕与强迫症最相关的关键神经科学主题组织内容。

主要发现

  • 症状维度有助于理解强迫症表型异质性并朝向更个体化治疗。
  • 异常恐惧消退概念是强迫症核心,也是暴露与反应阻止疗法治疗机制的基础。
  • 强迫症神经化学框架涵盖传统单胺能系统及近期谷氨酸能与γ-氨基丁酸能功能障碍证据。
  • 强迫症具有高度遗传性,未来需研究基因对 underlying pathophysiology 的贡献。
  • 环路失调框架聚焦皮层-纹状体-丘脑-皮层环路功能障碍及靶向该环路的神经治疗方法开发。

关键数值与推荐

  • 异常恐惧消退是强迫症核心概念及暴露与反应阻止疗法治疗机制基础。
  • 神经化学框架关注传统单胺能系统及谷氨酸能与γ-氨基丁酸能功能障碍证据。
  • 环路失调框架聚焦皮层-纹状体-丘脑-皮层环路功能障碍。

临床怎么用

  • 临床可将症状维度评估纳入强迫症个案概念化以支持个体化治疗规划。
  • 暴露与反应阻止疗法的机制理解可基于异常恐惧消退神经科学框架。
  • 神经化学与环路失调框架可为神经治疗靶点选择提供参考。

局限性

  • 本文为教育性综述,未报告原始研究数据或定量证据。
  • 文中指出理解基因对病理生理的贡献仍需未来研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Obsessive-compulsive disorder (OCD) is a common and often debilitating psychiatric illness. Recent advances in the understanding of the neuroscience of OCD have provided valuable insights that have begun to transform the way we think about the management of this disorder. This educational review provides an integrated neuroscience perspective on formulation and treatment planning for patients with OCD. The article is organized around key neuroscience themes most relevant for OCD. OBSERVATIONS: An integrated neuroscience formulation of OCD is predicated on a fundamental understanding of phenomenology and symptom dimensions, fear conditioning and extinction, neurochemistry, genetics and animal models, as well as neurocircuitry and neurotherapeutics. Symptom dimensions provide a means to better understand the phenotypic heterogeneity within OCD with an eye toward more personalized treatments. The concept of abnormal fear extinction is central to OCD and to the underlying therapeutic mechanism of exposure and response prevention. A framework for understanding the neurochemistry of OCD focuses on both traditional monoaminergic systems and more recent evidence of glutamatergic and γ-aminobutyric acid-ergic dysfunction. Obsessive-compulsive disorder is highly heritable, and future work is needed to understand the contribution of genes to underlying pathophysiology. A circuit dysregulation framework focuses on cortico-striato-thalamo-cortical circuit dysfunction and the development of neurotherapeutic approaches targeting this circuit. The impact of these concepts on how we think about OCD diagnosis and treatment is discussed. Suggestions for future investigations that have the potential to further enhance the clinical management of OCD are presented. CONCLUSIONS AND RELEVANCE: These key neuroscience themes collectively inform formulation and treatment planning for patients with OCD. The ultimate goal is to increase crosstalk between clinicians and researchers in an effort to facilitate translation of advances in neuroscience research to improved care for patients with OCD.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Dougherty DD, Brennan BP, Stewart SE, et al. Neuroscientifically Informed Formulation and Treatment Planning for Patients With Obsessive-Compulsive Disorder: A Review. JAMA Psychiatry. 2018. PMID: 30140845. doi:10.1001/jamapsychiatry.2018.0930

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。